Medeze Group PCL (BKK:MEDEZE)

Market Cap	7.21B
Revenue (ttm)	875.20M
Net Income (ttm)	322.37M
Shares Out	1.07B
EPS (ttm)	0.32
PE Ratio	20.86
Forward PE	16.46
Dividend	0.16 (2.35%)
Ex-Dividend Date	May 6, 2025

Volume	556,243
Average Volume	602,968
Open	6.80
Previous Close	6.75
Day's Range	6.75 - 7.00
52-Week Range	5.75 - 10.50
Beta	n/a
RSI	43.99
Earnings Date	Nov 13, 2025

About Medeze Group PCL

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition,...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Employees: 200
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEDEZE

Financial Performance

In 2024, Medeze Group PCL's revenue was 874.33 million, an increase of 23.60% compared to the previous year's 707.37 million. Earnings were 338.74 million, an increase of 41.40%.